Network-based analysis of vaccine-related associations reveals consistent knowledge with the vaccine ontology

Journal of Biomedical Semantics

Volumn 4, Issue 1, 2013, Pages

  Zhang, Yuji ^a   Tao, Cui ^b   He, Yongqun ^c   Kanjamala, Pradip ^a   Liu, Hongfang ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84915776731     PISSN: None     EISSN: 20411480     Source Type: Journal    
DOI: 10.1186/2041-1480-4-33     Document Type: Article

References (37)

1. Prevention, C.f.D.C.a: Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative. MMWR Morb Mortal Wkly Rep 1994,43(4):57-60.
2. Goldstein I, et al.: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil study group. N Engl J Med 1998,338(20):1397-1404.
3. Singhal S, et al.: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999,341(21):1565-1571.
4. Chong CR, Sullivan DJ Jr: New uses for old drugs. Nature 2007,448(7154):645-646.
5. Graul AI, et al.: The year's new drugs & biologics - 2009. Drug News Perspect 2010,23(1):7-36.
6. Ashburn TT, Thor KB: Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004,3(8):673-683.
7. Liu Z, et al.: In silico drug repositioning: what we need to know. Drug Discov Today 2013,18(3-4):110-115.
8. Ideker T, Sharan R: Protein networks in disease. Genome Res 2008,18(4):644-652.
9. Barabasi AL, Gulbahce N, Loscalzo J: Network medicine: a network-based approach to human disease. Nat Rev Genet 2011,12(1):56-68.
10. Berger SI, Iyengar R: Network analyses in systems pharmacology. Bioinformatics 2009,25(19):2466-2472.
11. Mathur S, Dinakarpandian D: Drug repositioning using disease associated biological processes and network analysis of drug targets. AMIA Annu Symp Proc 2011, 2011:305-311.
12. Hur J, et al.: Identification of fever and vaccine-associated gene interaction networks using ontology-based literature mining. J Biomed Semantics 2012,3(1):18.
13. Ozgur A, et al.: Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics 2008,24(13):i277-i285.
14. Ozgur A, et al.: Mining of vaccine-associated IFN-gamma gene interaction networks using the vaccine ontology. J Biomed Semantics 2011,2(Suppl 2):S8.
15. Ball R, Botsis T: Can network analysis improve pattern recognition among adverse events following immunization reported to VAERS? Clin Pharmacol Ther 2011,90(2):271-278.
16. Rindflesch TC, et al.: Semantic MEDLINE: an advanced information management application for biomedicine. Inf Serv & Use 2011,31(1/2):15-21.
17. Tao C, et al.: Optimizing Semantic MEDLINE for Translational Science Studies Using Semantic Web Technologies. Maui, Hawaii, USA: ACM; 2012:53-58. [Proceedings of the 2nd international workshop on Managing interoperability and compleXity in health systems2012]
18. The UMLS Semantic Groups 2012
19. Fekete A, Vattay G, Posfai M: Shortest path discovery of complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 2009, 79:065101.
20. Guess MJ, Wilson SB: Introduction to hierarchical clustering. J Clin Neurophysiol 2002,19(2):144-151.
21. Wilkinson L, Friendly M: The history of the cluster heat map. Am Stat 2009,63(2):179-184.
22. Smoot ME, et al.: Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011,27(3):431-432.
23. Xiang Z, et al.: OntoFox: web-based support for ontology reuse. BMC research notes 2010, 3:175.
24. Hartung HP, et al.: [Guillain-Barre syndrome after exposure to influenza]. Nervenarzt 2012,83(6):714-730.
25. Hemachudha T, et al.: Immunologic studies of rabies vaccination-induced Guillain-Barre syndrome. Neurology 1988,38(3):375-378.
26. Wardlaw AC: Animal models for pertussis vaccine neurotoxicity. Tokai J Exp Clin Med 1988,13(Suppl):171-175.
27. Corkins M, Grose C, Halbur T: Fatal pertussis in an Iowa infant. Iowa Med 1991,81(9):383-384.
28. Comenge Y, Girard M: Multiple sclerosis and hepatitis B vaccination: adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence. Med Hypotheses 2006,66(1):84-86.
29. Bozzola E, et al.: Neurological complications of varicella in childhood: case series and a systematic review of the literature. Vaccine 2012,30(39):5785-5790.
30. Friedrich F: Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. Acta virologica 1998,42(3):187-194.
31. Korsun N, et al.: Three cases of paralytic poliomyelitis associated with type 3 vaccine poliovirus strains in Bulgaria. J Med Virol 2009,81(9):1661-1667.
32. Hur J, et al.: Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network. BMC immunology 2011, 12:49.
33. Henderson R, et al.: General practitioners' concerns about childhood immunisation and suggestions for improving professional support and vaccine uptake. Commun Dis Public Health 2004,7(4):260-266.
34. Kornbluth RS: The emerging role of CD40 ligand in HIV infection. J Leukoc Biol 2000,68(3):373-382.
35. Kornbluth RS, Stone GW: Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J Leukoc Biol 2006,80(5):1084-1102.
36. Herren B, Burrows PD: B cell-restricted human mb-1 gene: expression, function, and lineage infidelity. Immunol Res 2002,26(1-3):35-43.
37. Sarntivijai S, et al.: Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines. PLoS One 2012,7(11):e49941.